DFX-18483-11230
4 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 210 / MD
- Registered
- 2021-10-22
- Relationship
- Child or adolescent in my care
- Guardian
- AE5-28572-28608
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-25
Dose 1 — Pfizer-BioNTech
-
2021-10-16
Dose 2 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-22
Registered in v-safe
- 2021-10-22
- 2021-10-23
- 2021-10-30
-
2021-11-08
Survey response — day 21, dose 2, dependentMedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Runny nose, coughing, maybe a coldMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-27
- 2022-01-15
-
2022-03-26
Dose 3 — Pfizer-BioNTech
- 2022-04-12
- 2022-04-16
- 2022-04-23
- 2022-05-02
- 2022-05-08
- 2022-06-25
- 2022-09-24
-
2022-11-23
Dose 4 — Pfizer-BioNTech
- 2022-11-28
- 2022-12-09
- 2022-12-22
- 2023-05-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-25 | Pfizer-BioNTech | No |
| 2 | 2021-10-16 | Pfizer-BioNTech | Flu |
| 3 | 2022-03-26 | Pfizer-BioNTech | No |
| 4 | 2022-11-23 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 2, dependent
Symptoms: Runny nose, coughing, maybe a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release